trending Market Intelligence /marketintelligence/en/news-insights/trending/dg9io6wd3imqtrblegxgia2 content esgSubNav
In This List

Eleven Biotherapeutics changes name to Sesen Bio

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Eleven Biotherapeutics changes name to Sesen Bio

Eleven Biotherapeutics Inc. is changing its name to Sesen Bio Inc.

The company's shares will start trading under the new name and Nasdaq ticker symbol SESN, effective May 17.

Eleven Biotherapeutics is a biologic oncology company that focuses on the design and development of targeted protein therapeutics addressing areas of unmet medical needs in cancer.